Showing results (671-680 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|September 21, 2011
MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphismsS A Owen, M Lunt, J Bowes, et al.
The Pharmacogenomics Journal|November 16, 2011
A genomic approach to predict synergistic combinations for breast cancer treatmentR Soldi, A L Cohen, L Cheng, et al.
The Pharmacogenomics Journal|October 12, 2011
The pharmacogenetics and pharmacogenomics of asthma therapyS M Tse, K Tantisira, S T Weiss
The Pharmacogenomics Journal|June 10, 2009
A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptomsP Gassó, S Mas, M Bernardo, et al.
The Pharmacogenomics Journal|December 14, 2011
Inter-ethnic differences in lymphocyte sensitivity to glucocorticoids reflect variation in transcriptional responseJ C Maranville, S S Baxter, J M Torres, et al.
The Pharmacogenomics Journal|January 4, 2012
Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic populationB Almoguera, R Riveiro-Alvarez, J Lopez-Castroman, et al.
The Pharmacogenomics Journal|February 23, 2022
Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic reviewJoseph O'Shea, Mark Ledwidge, Joseph Gallagher, et al.
The Pharmacogenomics Journal|October 17, 2019
Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severityDorothea Lesche, Sam Mostafa, Ian Everall, et al.
The Pharmacogenomics Journal|October 19, 2019
ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomideAnnika Malmström, Malgorzata Łysiak, Lisa Åkesson, et al.
The Pharmacogenomics Journal|October 13, 2021
Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockersLeonardo A Guerra, Christelle Lteif, Meghan J Arwood, et al.
Pageof 135